Biocon Limited (BOM:532523)
India · Delayed Price · Currency is INR 372.65
+8.10 (2.22%)
At close: Jan 22, 2026
Biocon Employees
Biocon had 16,315 employees as of March 31, 2024. The number of employees decreased by 230 or -1.39% compared to the previous year.
Employees
16,315
Change (1Y)
-230
Growth (1Y)
-1.39%
Revenue / Employee
10.03M INR
Profits / Employee
295.68K INR
Market Cap
603.65B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2024 | 16,315 | -230 | -1.39% |
| Mar 31, 2023 | 16,545 | 1,545 | 10.30% |
| Mar 31, 2022 | 15,000 | 1,500 | 11.11% |
| Mar 31, 2021 | 13,500 | 891 | 7.07% |
| Mar 31, 2020 | 12,609 | 1,266 | 11.16% |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Aarti Drugs | 1,284 |
| Hester Biosciences | 562 |
| Titan Biotech | 467 |
| Zenotech Laboratories | 228 |
| Hindustan Bio Sciences | 2 |
Biocon News
- 11 days ago - Pharma sector stocks down today: Divi’s Laboratories falls nearly 3%, Biocon drops 1.09%, Sun Pharma down 0.45% - Business Upturn
- 16 days ago - Top stocks to watch today, January 7: Titan Company, Mahindra, Godrej Consumer, Jubilant, Biocon and more - Business Upturn
- 23 days ago - Biocon employee found dead on Bengaluru campus, police probe underway - Business Upturn
- 23 days ago - Biocon staffer jumps to death from office building in Bengaluru - The Times of India
- 23 days ago - Biocon Employee, 26, Found Dead At Bengaluru Office - NDTV
- 4 weeks ago - Ajanta Pharma shares jump over 4% after signing in-licensing agreement with Biocon - Business Upturn
- 4 weeks ago - Biocon signs out-licensing deal with Ajanta Pharma to market Semaglutide in overseas markets - Business Upturn
- 4 weeks ago - Biocon Biologics secures full global rights for Hulio biosimilar Adalimumab - Business Upturn